Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: December 2014

HINJ Op-Ed: The Value of Medical Innovation: Saving Lives, Saving Money

New Brunswick, NJ, December 18, 2014 HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas has authored the following op-ed on the life sciences and the value of medical innovation.

*     *     *

Medical innovations produced by American life sciences companies have vastly improved the human condition.  Our pharmaceutical, biotech, medical technology, device and diagnostics companies have helped people live longer, with less pain and greater quality of life.

Over the past century, the life sciences has eradicated some of the world’s most dreaded diseases such as polio and smallpox.  More recently, the industry has made other diseases such as breast cancer, HIV/AIDS, heart disease and lung cancer no longer the death sentences that they once were.

Collectively, new therapies are the greatest contributors to increased life expectancy.  According to the National Bureau of Economic Research (NBER), between 1960 and 1997, new therapies accounted for 45 percent of the increase in life expectancy in 30 developing and high-income countries.  Between 2000 and 2009, new therapies accounted for 73 percent of the increased life expectancy for these countries.

Despite the dramatic life-saving advancements that the life sciences sector has made, our work is far from done.  Diabetes, Alzheimer’s, Ebola, different types of cancers, and other formidable medical conditions demonstrate the compelling need for America’s medical innovation community to build upon its tremendous achievements to continue saving lives around the world. Continue reading

BD CEO Vincent Forlenza Named Chairman of AdvaMed Board of Directors

Washington, DC, December 18, 2014 ― The Advanced Medical Technology Association (AdvaMed) has announced that BD Chairman, President and CEO Vincent A. Forlenza has been named chairman of the AdvaMed Board of Directors for a two-year term.   Forlenza succeeds Covidien Chairman, President and CEO Joe E. Almeida.

Forlenza has served on both the AdvaMed Board and its Executive Committee since 2010 and is the current chair of the association’s Board Committee on Technology and Regulation.   Continue reading

Rep. Leonard Lance to Chair Congressional Rare Disease Caucus

Washington, DC, December 17, 2014 ― Congressman Leonard Lance (NJ-07) has announced he will continue as the Republican Chair of the Congressional Rare Disease Caucus in the 114th Congress that will begin in January.  Lance has chaired the caucus for four years with Congressman Joe Crowley (NY-14), who will continue to serve as the Democratic Chair.

The Congressional Rare Disease Caucus is a forum for Members of Congress to voice constituent concerns, collaborate on ideas, facilitate conversations between the medical and patient community and build support for legislation that will improve the lives of people with rare diseases. Continue reading

CDC Year in Review: 10 Most Challenging Public-Health Threats of 2014

Atlanta, GA, December 16, 2014 ― It has been an unprecedented year for the Centers for Disease Control and Prevention (CDC), as America’s public health agency continues its emergency response to the most complex Ebola epidemic in history.  Ebola, however, is far from the only critical mission CDC undertook in 2014.

“CDC’s Ebola response is the largest global effort in the agency’s history, but we’re carrying out many other public-health missions crucial to protecting American lives,” said CDC Director Tom Frieden, M.D., M.P.H. “We’re taking action on a wide range of health threats.”

In a digital press kit released yesterday, CDC reviews its responses to the 10 most important public-health challenges of 2014: Continue reading

‘Nanomeds’: Tiny Sensors May Soon Monitor Patients’ Medicines from Inside

Washington, DC, December 15, 2014 ― Frank Browning reports on Kaiser Family Health about a medical innovation called “nanomeds” that are miniscule sensors embedded in a placebo pill that the patient swallow.

Browning reports that these “ingestibles” — which are the size of BBs and, actually, not digested by the body — are switched on by contact with saliva and/or gastric juices.  The signal then is picked up by another sensor which looks like a Band-Aid and is worn on your chest.

This system records medicine intake as well as other measures, such as heart rate. The information shows up on your smartphone or tablet, via Bluetooth and can automatically go to your doctors, family members or caregivers, with your permission. Continue reading

Attorney General Report: 20,000 NJ Physicians Signed Up for Prescription Monitoring Program Access in 2014

Newark, NJ, December 12, 2014 ― Approximately 20,000 New Jersey physicians and 5,000 other licensed healthcare practitioners this year gained direct access to the New Jersey Prescription Monitoring Program (NJPMP), a significant milestone in the fight against the deadly epidemic of opiate abuse.

As of today, 85 percent of New Jersey’s physicians – or 25,501 of the State’s eligible physicians – are able to access the NJPMP. This represents a 467 percent increase since December 2013, when approximately 4,500 physicians had NJPMP access.

Additionally, 56 percent of all healthcare practitioners in New Jersey – or 35,500 of the State’s eligible prescribers and pharmacists of all kinds – have direct access to the prescription-tracking database.  This represents a 256 percent increase since December 2013, when 9,965 healthcare practitioners had access to the NJPMP. Continue reading

Watch: Sens. Menendez and Booker Discuss Obamacare, Other Key Issues

Newark, NJ, December 11, 2014 ― Steve Adubato’s one-hour interview with US Senators Robert Menendez and Cory Booker aired Wednesday on PBS and via streaming at NJ.com.

On the topic of the Affordable Care Act, while supportive of the overall act, Sen. Booker acknowledged (at 36:50) there was room for change.

“One [change] that is very important for the state of New Jersey…is the medical device tax,” Senator Booker said.  “One of the ways some of the aspects of [ACA] are being paid for…are to tax medical devices, and, for me, that is inhibiting a lot of New Jersey businesses and affecting a lot of New Jersey jobs.”  Continue reading

New Jersey Hospitals Contribute $21 Billion to State Economy in 2013, Reports NJ Hospital Association

Princeton, NJ, December 11, 2014 ― New Jersey hospitals continued to play key roles as strong contributors to New Jersey’s economy and as healthcare safety nets by contributing almost $21 billion to the Garden State economy in 2013, according to the 2014 N.J. Hospitals Economic Impact Report released yesterday by the New Jersey Hospital Association.

Even as the healthcare landscape continues to change, New Jersey hospitals supplied 144,000 full- and part-time jobs in 2013.  Hospital activity in area such as goods and services purchased from other businesses and state income taxes paid by employees also increased. Continue reading

Rowan University Starts Biomedical Engineering Program, Appoints Chairman

Glassboro, NJ, December 10, 2014 ― New Jersey Business reports that Rowan University welcomed its first class of biomedical engineering students this year as its nationally recognized College of Engineering recently created the Biomedical Engineering Department.

The program is at the intersection of medicine and biology, with the focus on the improvement of heath care systems and is modeled after the proven hands-on, real-world, project-based curriculum of Rowan’s existing engineering programs.

Rowan University also named Dr. Mark Byrne as professor and inaugural chairman of the new department.  A leader in the field of biomaterials engineering, controlled therapeutic delivery, pharmaceutical engineering, polymer engineering and medical devices, Byrne has won numerous awards for his teaching and research and has licensed a number of innovative technologies. Continue reading

15 NJ Health Centers Receive Affordable Care Act Grant Money

Washington, DC, December 10, 2014 ― Beth Fitzgerald reports in NJBIZ that the US Department of Health and Human Serves yesterday awarded more than a half-million dollars in Affordable Care Act grants to 15 of New Jersey’s 20 federally funded health centers, which provide medical care in low- and moderate-income communities statewide.

In making the announcement, HHS Sylvia M. Burwell said the $510,008 in ACA grants recognize those health centers that have achieved certain quality milestones and are making ongoing investment in health care quality improvement. Continue reading